Stock Updates

Is this Large Market Cap Stock target price reasonable for Bristol-Myers Squibb Company (NYSE:BMY)?

The company in question is, Bristol-Myers Squibb Company (NYSE:BMY) currently with a stock price of 49.77 (-0.94% today). The market cap for Bristol-Myers Squibb Company is 83944.07, and is in the sector Healthcare, and Drug Manufacturers РMajor industry. The target price for Bristol-Myers Squibb Company is 65.9. Currently Bristol-Myers Squibb Company is trading with a P/E of 29.12, and a forward P/E of 17.02. Average volume for Bristol-Myers Squibb Company is 13754.89 and so far today it is 13826400.

Performance in the last year for Bristol-Myers Squibb Company has been -19.90%. For EPS growth, Bristol-Myers Squibb Company has seen a growth of -22.30%, and is looking to grow in the next year to 11.39%. More long term stats show that EPS growth has been -12.20% over the last five years and could be 16.87% for the next five years. Bristol-Myers Squibb Company has seen sales growth quarter over quarter at 17.00%, with EPS growth quarter over quarter at 990.60%. The 20-day simple moving average is -12.25%, with the 200-day simple moving average coming to -23.07%.

Since the IPO date for Bristol-Myers Squibb Company on the 6/1/1972, Bristol-Myers Squibb Company has seen performance year to date to be -26.33%. With Bristol-Myers Squibb Company trading at 49.77, the dividend yield is 3.05%, and the EPS is 1.71.

So could Bristol-Myers Squibb Company, be undervalued? Well as said before P/E is 29.12. The PEG is 1.73, P/S is 4.76 and the P/B is at 5.57. The P/cash is 18.05, with P/free cash flow at *TBA.

Bristol-Myers Squibb Company ability to deal with debt shows that the current ratio is 1.6, and the quick ratio is 1.4. This is with long term debt/equity at 0.44, and total debt/equity at 0.45.

In terms of margins, Bristol-Myers Squibb Company has a gross margin of 75.70%, an operating margin of 20.80% and a profit margin of 16.30%.Payout ratio for Bristol-Myers Squibb Company is 87.80%. Return on assets come to 9.00% with return on investment coming to 4.60%.

Insider ownership for Bristol-Myers Squibb Company, is at 0.10% and institutional ownership comes to 74.10%. Outstanding shares are at 1686.64. While shares float is 1504.56. The float short is currently 0.94%, and short ratio is 1.02.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment